A hydroquinone formulation with increased stability and decreased potential for irritation

Area of Science:

• Dermatology
• Cosmetic Science
• Formulation Chemistry

Background:

• Traditional 4% hydroquinone (HQ) creams are standard for hyperpigmentation but suffer from instability and irritation, impacting patient compliance.
• A novel 4% HQ formulation incorporates an antioxidant for improved stability and a biomimetic herbal extract for skin soothing.
• Addressing limitations of current hyperpigmentation treatments is crucial for patient outcomes.

Purpose of the Study:

• To assess the efficacy, stability, and irritancy profile of a new 4% HQ cream.
• To compare the new formulation against existing commercial 4% HQ products.
• To evaluate the potential of the new formulation to improve patient compliance.

Main Methods:

• Stability testing via temperature stress tests.
• Irritancy assessment using repeated-insult patch tests on human subjects.
• Skin lightening efficacy evaluated using the MelanoDerm B skin equivalent model.

Main Results:

• The new 4% HQ formulation exhibited superior resistance to browning and reduced irritancy compared to three commercial 4% HQ creams.
• Its skin-lightening effect was comparable to a combination product (4% HQ, 0.05% tretinoin, 0.01% fluocinolone acetonide) but with a faster onset.
• The formulation showed promising results in both in vitro and human subject testing.

Conclusions:

• The new 4% HQ formulation offers improved stability and lower irritancy, suggesting enhanced therapeutic potential.
• This formulation may lead to better treatment adherence and outcomes for hyperpigmentation disorders.
• Innovative formulation strategies can overcome challenges associated with traditional hydroquinone therapies.